Insider Transactions in Q2 2021 at Abiomed Inc (ABMD)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 21
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
SELL
Open market or private sale
|
Direct |
25,000
-5.38%
|
$8,125,000
$325.6 P/Share
|
Jun 21
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+9.56%
|
$575,000
$23.15 P/Share
|
May 30
2021
|
David M Weber CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
300
-0.24%
|
$95,100
$317.88 P/Share
|
May 29
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,563
-0.73%
|
$443,892
$284.58 P/Share
|
May 29
2021
|
Todd A Trapp VICE PRESIDENT, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
518
-5.1%
|
$147,112
$284.58 P/Share
|
May 29
2021
|
David M Weber CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
449
-0.36%
|
$127,516
$284.58 P/Share
|
May 29
2021
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
366
-0.96%
|
$103,944
$284.58 P/Share
|
May 29
2021
|
Marc A Began VP & GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
480
-7.42%
|
$136,320
$284.58 P/Share
|
May 25
2021
|
Marc A Began VP & GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+23.61%
|
-
|
May 25
2021
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+4.98%
|
-
|
May 25
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,503
+3.84%
|
-
|
May 25
2021
|
Todd A Trapp VICE PRESIDENT, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,021
+16.6%
|
-
|
May 25
2021
|
David M Weber CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,687
+2.08%
|
-
|
May 19
2021
|
Martin P Sutter |
SELL
Open market or private sale
|
Direct |
3,750
-2.17%
|
$1,001,250
$267.44 P/Share
|
May 18
2021
|
Martin P Sutter |
SELL
Open market or private sale
|
Direct |
3,750
-2.12%
|
$997,500
$266.72 P/Share
|
May 16
2021
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
826
-1.12%
|
$221,368
$268.56 P/Share
|
May 16
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,158
-1.47%
|
$1,650,344
$268.56 P/Share
|
May 16
2021
|
Todd A Trapp VICE PRESIDENT, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
310
-3.67%
|
$83,080
$268.56 P/Share
|
May 16
2021
|
David M Weber CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,282
-0.51%
|
$343,576
$268.56 P/Share
|
May 03
2021
|
David M Weber CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
12,700
-0.96%
|
$3,949,700
$311.01 P/Share
|
May 03
2021
|
David M Weber CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+8.61%
|
$299,000
$23.15 P/Share
|
Apr 26
2021
|
Paula A Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
717
+50.0%
|
-
|
Apr 09
2021
|
Todd A Trapp VICE PRESIDENT, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
936
-9.98%
|
$307,944
$329.75 P/Share
|